Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00468871 | Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant vs Standardized Therapy | PHASE2 | COMPLETED | 140 | — | — | Apr 1, 2002 | Jun 1, 2006 | Dec 8, 2011 | - | — |
| Arm | Type | Description |
|---|---|---|
| Fluocinolone acetonide | EXPERIMENTAL | Intravitreal fluocinolone acetonide implant |
| Standard care | ACTIVE_COMPARATOR | Standard of Care |
| Name | Type | Description |
|---|---|---|
| fluocinolone acetonide intravitreal implant | DRUG | surgical intravitreal implant of fluocinolone acetonide |
| corticosteroids and immunosuppressants | DRUG | Systemic corticosteroids alone or combined with immunosuppressants |
Inclusion Criteria: * Males and non-pregnant females at least 6 years of age * History of recurrent unilateral or asymmetric non-infectious posterior uveitis of at east 1 year duration not associated with significant systemic activity of the disease * The more severely affected eye having had at le...